Massachusetts Financial Services’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $749M | Sell |
1,935,880
-300,249
| -13% | -$111M | 0.24% | 108 |
|
|
2026
Q1 | $657M | Sell |
2,236,129
-124,729
| -5% | -$41M | 0.22% | 114 |
|
|
2025
Q4 | $828M | Sell |
2,360,858
-79,772
| -3% | -$27M | 0.27% | 100 |
|
|
2025
Q3 | $789M | Buy |
2,440,630
+112,020
| +5% | +$34.8M | 0.24% | 107 |
|
|
2025
Q2 | $906M | Sell |
2,328,610
-98,218
| -4% | -$39.5M | 0.29% | 100 |
|
|
2025
Q1 | $1.06B | Sell |
2,426,828
-62,083
| -2% | -$24.9M | 0.35% | 82 |
|
|
2024
Q4 | $918M | Buy |
2,488,911
+91,653
| +4% | +$38.4M | 0.29% | 93 |
|
|
2024
Q3 | $1.25B | Buy |
2,397,258
+334,552
| +16% | +$179M | 0.37% | 80 |
|
|
2024
Q2 | $1.12B | Buy |
2,062,706
+523,910
| +34% | +$277M | 0.34% | 85 |
|
|
2024
Q1 | $798M | Buy |
1,538,796
+548,168
| +55% | +$273M | 0.24% | 110 |
|
|
2023
Q4 | $467M | Buy |
+990,628
| New | +$458M | 0.15% | 156 |
|
|
2019
Q4 | – | Sell |
-1,706
| Closed | -$410K | – | 814 |
|
|
2019
Q3 | $410K | Buy |
1,706
+18
| +1% | +$4.93K | ﹤0.01% | 802 |
|
|
2019
Q2 | $476K | Buy |
+1,688
| New | +$461K | ﹤0.01% | 816 |
|
|
2017
Q4 | – | Sell |
-43,079
| Closed | -$8.18M | – | 849 |
|
|
2017
Q3 | $8.18M | Buy |
43,079
+971
| +2% | +$185K | ﹤0.01% | 626 |
|
|
2017
Q2 | $7.92M | Buy |
42,108
+10,993
| +35% | +$1.98M | ﹤0.01% | 632 |
|
|
2017
Q1 | $5.15M | Sell |
31,115
-6,841
| -18% | -$1.09M | ﹤0.01% | 654 |
|
|
2016
Q4 | $5.46M | Sell |
37,956
-5,161
| -12% | -$691K | ﹤0.01% | 654 |
|
|
2016
Q3 | $5.4M | Sell |
43,117
-293,493
| -87% | -$37.9M | ﹤0.01% | 639 |
|
|
2016
Q2 | $44.2M | Buy |
336,610
+294,166
| +693% | +$40.2M | 0.02% | 362 |
|
|
2016
Q1 | $5.9M | Sell |
42,444
-144,786
| -77% | -$19.3M | ﹤0.01% | 624 |
|
|
2015
Q4 | $26.1M | Sell |
187,230
-180,705
| -49% | -$24.9M | 0.01% | 453 |
|
|
2015
Q3 | $51.5M | Sell |
367,935
-221,307
| -38% | -$33.3M | 0.03% | 326 |
|
|
2015
Q2 | $96.7M | Sell |
589,242
-85,437
| -13% | -$13.7M | 0.05% | 261 |
|
|
2015
Q1 | $104M | Sell |
674,679
-181,733
| -21% | -$25.9M | 0.05% | 250 |
|
|
2014
Q4 | $108M | Buy |
856,412
+73,206
| +9% | +$9.05M | 0.05% | 236 |
|
|
2014
Q3 | $93.7M | Sell |
783,206
-114,753
| -13% | -$13.2M | 0.05% | 256 |
|
|
2014
Q2 | $96.6M | Sell |
897,959
-28,028
| -3% | -$2.89M | 0.05% | 255 |
|
|
2014
Q1 | $92.2M | Buy |
925,987
+83,337
| +10% | +$7.54M | 0.05% | 264 |
|
|
2013
Q4 | $77.9M | Buy |
842,650
+63,839
| +8% | +$5.67M | 0.04% | 285 |
|
|
2013
Q3 | $65.1M | Buy |
778,811
+55,070
| +8% | +$4.72M | 0.04% | 295 |
|
|
2013
Q2 | $59.2M | Buy |
+723,741
| New | +$54.2M | 0.04% | 298 |
|
Other funds holding ELV
AACR
HGIM
Massachusetts Financial Services's ELV Position: Q2 2026 in Review
Massachusetts Financial Services reduced its Elevance Health (ELV) stake by 13% in Q2 2026, selling an estimated $111M and leaving 1,935,880 shares worth $749M. The position accounts for 0.24% of the portfolio, ranked #108.
Massachusetts Financial Services first reported a position in ELV in Q2 2013 and has held it in 31 quarters since. The position peaked at $1.25B in Q3 2024. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Massachusetts Financial Services held 1,935,880 shares of Elevance Health worth $749M as of Q2 2026.
- Massachusetts Financial Services sold 300,249 Elevance Health shares in Q2 2026, an estimated $111M.
- Elevance Health made up 0.24% of Massachusetts Financial Services's portfolio in Q2 2026, its #108 holding.
- Massachusetts Financial Services first reported a position in Elevance Health in Q2 2013 and has held it in 31 quarters since.
- Massachusetts Financial Services's Elevance Health position peaked at $1.25B in Q3 2024.
- 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.